| Applications: |
Immunodepletion/Immunocompetition |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
IL32 Blocking Peptide for STJ501446 is synthetically produced from the 180-234 sequence and is suitable for use in western blot applications. |
| Formulation: |
Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: |
Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Gene Symbol: |
IL32 |
| Gene ID: |
9235 |
| Uniprot ID: |
IL32_HUMAN |
| Immunogen Region: |
180-234 |
| Specificity: |
This blocking peptide is recommended for use in combination with IL32 antibody, STJ501446 |
| Immunogen: |
Synthetic pepetide taken within amino acid region 180-234 on human Interleukin-32 (natural killer cells protein 4). The synthetic peptide was post-synthetically modified and conjugated to KLH to achieve desired antigenicity. |
| Tissue Specificity | Selectively expressed in lymphocytes. Expression is more prominent in immune cells than in non-immune cells. |
| Function | Cytokine that may play a role in innate and adaptive immune responses. It induces various cytokines such as TNFA/TNF-alpha and IL8. It activates typical cytokine signal pathways of NF-kappa-B and p38 MAPK. |
| Peptide Name | Interleukin-32Il-32Natural Killer Cells Protein 4Tumor Necrosis Factor Alpha-Inducing Factor |
| Database Links | Reactome: R-HSA-449836Reactome: R-HSA-9013423 |
| Cellular Localisation | Secreted |
| Alternative Peptide Names | Interleukin-32 proteinIl-32 proteinNatural Killer Cells Protein 4 proteinTumor Necrosis Factor Alpha-Inducing Factor proteinIL32 proteinNK4 proteinTAIF protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
